![Claudio Soto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Claudio Soto
Sociétés | Poste | Début | Fin |
---|---|---|---|
Amprion, Inc.
![]() Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Directeur Technique/Scientifique/R&D | - | - |
Fondateur | - | - |
Historique de carrière de Claudio Soto
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Amprion, Inc.
![]() Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Health Technology |
- Bourse
- Insiders
- Claudio Soto
- Expérience